20428724

Costa EC

2010

[Central obesity index and cardiovascular risk factors in polycystic ovary syndrome].

20430377

Sova H

2010

Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.

20431891

Yang JH

2010

A comparative study of cutaneous manifestations of hyperandrogenism in obese and non-obese Taiwanese women.

20432811

Shah B

2010

Unilateral ovarian enlargement in adolescents with polycystic ovary syndrome: a variant of bilateral disease.

20435271

Brodell LA

2010

Hirsutism: Diagnosis and management.

20435290

Carmina E

2010

The diagnosis of polycystic ovary syndrome in adolescents.

20435692

Johnson NP

2010

PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene.

20435693

Tehrani FR

2010

Is polycystic ovary syndrome an exception for reproductive aging?

20436797

Sam S

2007

Obesity and Polycystic Ovary Syndrome.

20439247

Freeman R

2010

Assessing impaired glucose tolerance and insulin resistance in polycystic ovarian syndrome with a muffin test: an alternative to the glucose tolerance test.

20440089

Zabuliene L

2010

[Body composition and polycystic ovary syndrome].

20441061

Sohrabvand F

2009

Effect of metformin on miscarriage in pregnant patients with polycystic ovary syndrome.

20444918

Ackerman CM

2010

The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size.

20444933

Segars JH

2010

Is there a genetic basis for polycystic ovary syndrome?

20450755

Gao GH

2010

[Polymorphism of CYP11A1 gene in Chinese patients with polycystic ovarian syndrome].

20450840

Peng CY

2010

Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women.

20451181

Jungheim ES

2010

Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.

20451188

Cupisti S

2010

The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome.

20452586

Kwon H

2010

mRNA expression pattern of insulin-like growth factor components of granulosa cells and cumulus cells in women with and without polycystic ovary syndrome according to oocyte maturity.

20453076

Akamine EH

2010

Obesity induced by high-fat diet promotes insulin resistance in the ovary.

20453465

Utriainen P

2010

Serum anti-m?llerian hormone concentrations in prepubertal girls with and without premature adrenarche: The influence of body mass index.

20455724

Karaer A

2010

Cardiovascular risk factors in polycystic ovary syndrome.

20455892

Semple RK

2010

What is the best management strategy for patients with severe insulin resistance?

20456207

Stadtmauer L

2010

The significance of the first Latin American Consensus on polycystic ovary syndrome.

20456209

Motta AB

2010

Report of the international symposium: polycystic ovary syndrome: first Latin-American consensus.

20457438

Li HY

2010

A comprehensive approach for the initial adolescent gynecological visit.

20458488

Iavazzo C

2010

Polycystic ovarian syndrome and pregnancy outcome.

20462044

Wang XX

2010

[Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary].

20462080

Wongwananuruk T

2010

Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital.

20462081

Pantasri T

2010

Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome.

20464708

Lenarcik A

2010

Cardiopulmonary functional capacity and the role of exercise in improving maximal oxygen consumption in women with PCOS.

20465786

Ott J

2010

Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study.

20465849

Liu JJ

2010

Downregulation of both gene expression and activity of Hsp27 improved maturation of mouse oocyte in vitro.

20470471

Moreira S

2010

[Polycystic ovary syndrome: a psychosocial approach].

20471009

Farrell K

2010

Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.

20473763

Baran S

2010

Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome.

20477880

Vural P

2010

Vascular endothelial growth factor +405 G/C,-460 T/C and -2578 A/C polymorphisms are not associated with insulin resistance in polycystic ovary syndrome.

20481031

Lindenbaum C

2010

Polycystic ovarian syndrome. Where genetics and environment collide.

20482693

Zouboulis CC

2010

[Hormonal antiandrogens in acne treatment].

20483671

Smith CA

2010

Acupuncture to treat common reproductive health complaints: An overview of the evidence.

20484445

Marsh KA

2010

Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome.

20484478

Insenser M

2010

Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation.

20486876

Ucok K

2010

Assessment of pulmonary functions and anthropometric measurements in women with polycystic ovary syndrome.

20486877

Gorar S

2010

Serum fibroblast growth factor 21 levels in polycystic ovary syndrome.

20486878

Selcoki Y

2010

Cardiac flow parameters with conventional and pulsed tissue Doppler echocardiography imaging in patients with polycystic ovary syndrome.

20492363

McCartney CR

2010

Maturation of sleep-wake gonadotrophin-releasing hormone secretion across puberty in girls: potential mechanisms and relevance to the pathogenesis of polycystic ovary syndrome.

20492387

Yanazume Y

2010

Difference in non-weight-bearing effects on bone mineral density between trunk and peripheral fat mass in women with polycystic ovary syndrome.

20493471

Hanzu FA

2010

Association of insulin receptor genetic variants with polycystic ovary syndrome in a population of women from Central Europe.

20493476

Kaya MG

2010

An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome.

20493742

Wiwanitkit V

2011

Insulin resistance and polycystic ovary syndrome.

20498127

Groth SW

2010

Adiponectin and polycystic ovary syndrome.

20499766

Ikechebelu JI

2010

Pregnancy following laparoscopic ovarian drilling for clomiphene resistant polycystic ovarian syndrome.

20500100

Ib??ez L

2010

Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.

20500101

Pusalkar M

2010

Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes.

20500102

F?bregues F

2011

The effect of different hormone therapies on anti-m?llerian hormone serum levels in anovulatory women of reproductive age.

20500103

Huang JH

2010

Cardiac conductive disturbance in patients with polycystic ovary syndrome.

20500107

Lindholm A

2010

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome.

20500115

Chun-Sen H

2011

Obesity and insulin resistance in women with polycystic ovary syndrome.

20500948

Cheung AP

2010

Polycystic ovary syndrome: a contemporary view.

20500954

Colwell K

2010

Women's perceptions of polycystic ovary syndrome following participation in a clinical research study: implications for knowledge, feelings, and daily health practices.

20500959

Vause TD

2010

Ovulation induction in polycystic ovary syndrome.

20500960

Vause TD

2010

[Ovulation induction in polycystic ovary syndrome].

20502465

Hickey TE

2010

Biomarkers: Polycystic ovary syndrome: steroid assessment for diagnosis.

20504100

Su HW

2011

Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.

20504101

P?rez-Bravo F

2010

Serological markers of autoimmunity in pregnant women with polycystic ovary syndrome: a pilot study.

20504873

Son WY

2010

Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries.

20506828

Xie Y

2010

[Effects of Bushen Tongmai recipe on expression of IRS-1 Ser307 in polycystic ovarian syndrome rats accompanying with insulin resistance].

20510769

Rathnayake D

2010

Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.

20511727

Cakal E

2011

Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome.

20512258

Rodrigues JK

2010

[Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls].

20512259

Cerqueira JM

2010

[Homocysteinemia in polycystic ovary syndrome women].

20513336

Qin B

2010

Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes.

20514429

Gu BH

2010

Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome.

20515429

Silderhuis VM

2010

Abdominal abscesses with Streptococcus milleri group after laparoscopic chromopertubation.

20516250

Harrison S

2010

Update on the management of hirsutism.

20517830

Boudhr?a K

2010

[Indication of metformin in the management of hormonal dysfunction secondary to polycystic ovarian syndrome: prospective comparative study of 63 cases].

20519354

Phelan N

2010

Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.

20528205

de Fran?a Neto AH

2010

Oncological repercussions of polycystic ovary syndrome.

20528206

Zhong G

2011

Serum and follicular fluid levels of IGF-II, IGF-binding protein-4 and pregnancy-associated plasma protein-A in controlled ovarian hyperstimulation cycle between polycystic ovarian syndrome (PCOS) and non-PCOS women.

20528207

Kebapcilar L

2011

Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.

20528321

Upadhya K

2007

Effects of polycystic ovary syndrome on health-related quality of life.

20528570

Glintborg D

2010

Thiazolinedione treatment in PCOS--an update.

20530094

Tao T

2010

Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance.

20534766

Koval KW

2010

Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.

20535365

Kargili A

2010

Association of polycystic ovary syndrome and a non-dipping blood pressure pattern in young women.

20536945

Tomlinson J

2010

Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?

20537145

Schuster J

2010

Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS).

20537572

Ozgen IT

2010

Characteristics of polycystic ovarian syndrome and relationship with ghrelin in adolescents.

20537860

Hannoun A

2011

Vocal changes in patients with polycystic ovary syndrome.

20540665

Bhattacharya SM

2010

Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions.

20540677

Angioni S

2011

The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome.

20546140

Thomson RL

2011

Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.

20547115

Quintero-Castillo D

2010

[Lipid profile in obese and non-obese women with polycystic ovary syndrome treated with metformin].

20551072

Kassanos D

2010

Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study.

20551845

Veltman-Verhulst SM

2010

Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk.

20553676

Pournaras DJ

2010

Polycystic ovary syndrome is common in patients undergoing bariatric surgery in a British center.

20555001

Baka S

2010

Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation.

20555028

Veiga-Lopez A

2010

Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep.

20558990

Hara S

2010

Usefulness of bezafibrate for ovulation induction in clomiphene citrate-resistant polycystic ovary syndrome patients with dyslipidemia: a prospective pilot study of seven cases.

20561613

Gowri V

2010

High-sensitivity C-reactive protein is a marker of obesity and not of polycystic ovary syndrome per se.